Your Source for Venture Capital and Private Equity Financings

Vernal Biosciences Launches with Seed Funding

BURLINGTON, VT, Vernal Biosciences announced the closing of a seed round of financing.
Vernal Biosciences, a manufacturer of high purity mRNA for research and clinical use, announced the closing of a seed round of financing.

Alloy Therapeutics led the round and was joined by the Vermont Center for Emerging Technologies and individual angel investors.

Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis. The company is experienced at overcoming the bottlenecks involved in mRNA-based R&D with reliable, high-purity manufacturing, and an approach rooted in a quality-first culture and deep regulatory experience.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading